this post was submitted on 06 Jan 2024
309 points (95.8% liked)

Technology

72320 readers
2655 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related news or articles.
  3. Be excellent to each other!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, this includes using AI responses and summaries. To ask if your bot can be added please contact a mod.
  9. Check for duplicates before posting, duplicates may be removed
  10. Accounts 7 days and younger will have their posts automatically removed.

Approved Bots


founded 2 years ago
MODERATORS
 

A gel injected into the scrotum could be the next male contraceptive::Biotech company Contraline has safely implanted a sperm-blocking hydrogel in 23 men. It’s designed to be a fully reversible vasectomy.

you are viewing a single comment's thread
view the rest of the comments
[–] KinNectar@kbin.run 71 points 2 years ago* (last edited 2 years ago) (4 children)

Vaselgel is too cheap to manufacture to get the funding it needs to bring it to market, that's why they have been trying for 20 years and haven't succeeded yet. In the US the rights are owned by a non profit Parsemu Foundation formed to fund it. It looks like their private partner NEXT Life Sciences is actually set to come to market with a vaselgel product in 2026 they are calling Plan A.

https://www.prnewswire.com/news-releases/next-life-sciences-announces-launch-of-plan-a-birth-control-for-men-301779007.html

Interesting marketing choice comparing it to the Plan B pill.

[–] jhulten@infosec.pub 24 points 2 years ago (2 children)

If Plan A works, you don't need Plan B... 😄

[–] Willy@sh.itjust.works 10 points 2 years ago

I think that was always the point of the name. this would just be a new plan A.

load more comments (1 replies)